ClinConnect ClinConnect Logo
Search / Trial NCT06844903

Effect of Ultrasound Acupoints on Patients With Polycystic Ovary Syndrome

Launched by KAFRELSHEIKH UNIVERSITY · Feb 20, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the effects of ultrasound treatment on women with Polycystic Ovary Syndrome (PCOS). PCOS can cause issues like irregular periods and hormone imbalances, and this study aims to see if using ultrasound on specific points in the body can help improve these symptoms. The trial is currently looking for women aged 18 to 35 who have irregular menstrual cycles. To participate, they must also meet certain health criteria, such as not having any serious medical conditions or taking medications that could interfere with the study results.

Participants in this trial can expect to undergo ultrasound treatments while their menstrual cycles and hormone levels are monitored. It's important to note that women who have certain health issues, like cancer, severe heart or lung problems, or those who refuse to stop specific medications, will not be eligible to join. Overall, this study hopes to find a new way to help manage PCOS symptoms and improve the quality of life for those affected.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Adults range between 18 and 35 years.
  • All patients will be stopped drugs that affect the result during study period.
  • body mass index (BMI) not exceeding 30 kg/m2.
  • have the symptoms of oligomenorrhea or amenorrhea (appendix I).
  • No documented or observable psychiatric or neurological disorders that would interfere with study participation (eg, dementia or psychosis).
  • Not having any type of cancer.
  • Exclusion Criteria:
  • Any malignancy
  • Patients with severe or unstable cardiorespiratory or musculoskeletal diseases that may influence the accuracy of quantitative sensory testing results.
  • Participants who refuse to stop the drugs that affect the study during study period.
  • Contraindications to therapeutic ultrasound including active cancer in region of hands or feet, presence of deep vein thrombosis, complete numbness in hands or feet, metal or plastic implantation.

About Kafrelsheikh University

Kafrelsheikh University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that contribute to the enhancement of healthcare practices and patient outcomes. With a strong emphasis on interdisciplinary collaboration, the university harnesses its diverse expertise in medical sciences, engineering, and technology to conduct rigorous clinical studies. Kafrelsheikh University aims to foster innovation in clinical research, ensuring compliance with ethical standards and regulatory requirements, while actively engaging in community health initiatives to address pressing health challenges. Through its commitment to excellence, the university seeks to develop evidence-based solutions that improve health and well-being at both local and global levels.

Locations

Mansoura, , Egypt

Patients applied

0 patients applied

Trial Officials

Fayiz Farouk El Shamy, PhD

Study Chair

Professor, Kafrelsheikh university

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported